• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚腺苷二磷酸核糖聚合酶 1(PARP1)在病理性心肌肥厚过程中与信号转导与转录激活因子 3(STAT3)相互作用,并将其保留在细胞核内的活性磷酸化状态。

PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy.

机构信息

Department of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, PR China; National and Local United Engineering Lab of Druggability and New Drugs Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, PR China.

Bank of China Ltd., Guangzhou 510610, PR China.

出版信息

Mol Cell Endocrinol. 2018 Oct 15;474:137-150. doi: 10.1016/j.mce.2018.02.020. Epub 2018 Mar 1.

DOI:10.1016/j.mce.2018.02.020
PMID:29501586
Abstract

The activation of signal transducer and activator of transcription 3 (STAT3) positively regulates myocardial hypertrophy, and its transcriptional activity is finely conditioned by diverse extracellular growth factors and cytokines. Here, we introduce novel evidence that poly(ADP-ribose) polymerase 1 (PARP1) interacts with STAT3 and promotes its activation in cardiomyocytes and rat heart tissues. PARP1 activity and phosphorylated STAT3 were augmented by hypertrophic stimuli both in vitro and in vivo. Infection of PARP1 adenovirus induced cardiomyocyte hypertrophy, which could be prevented by STAT3 knockdown or inhibition. Additionally, PARP1 enhanced STAT3 phosphorylation level, nuclear accumulation and transcriptional activity. Mechanistically, PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus. In conclusion, our findings provide the first evidence that PARP1 exacerbates cardiac hypertrophy by stabilizing active phosphorylated-STAT3, which suggests that multi-target therapeutic strategies counteracting PARP1 activity and STAT3 activation would be potential for treating cardiovascular diseases.

摘要

信号转导子和转录激活子 3(STAT3)的激活正向调节心肌肥大,其转录活性受到多种细胞外生长因子和细胞因子的精细调节。在这里,我们介绍了新的证据,表明多聚(ADP-核糖)聚合酶 1(PARP1)与 STAT3 相互作用,并促进其在心肌细胞和大鼠心脏组织中的激活。PARP1 活性和磷酸化 STAT3 在体外和体内均由肥大刺激物增强。PARP1 腺病毒感染诱导心肌细胞肥大,这可以通过 STAT3 敲低或抑制来预防。此外,PARP1 增强了 STAT3 的磷酸化水平、核积累和转录活性。从机制上讲,PARP1 与 STAT3 相互作用,并将活性磷酸化-STAT3 保留在核内。总之,我们的研究结果首次提供了证据表明,PARP1 通过稳定活性磷酸化-STAT3 加剧心脏肥大,这表明针对 PARP1 活性和 STAT3 激活的多靶点治疗策略可能是治疗心血管疾病的潜在方法。

相似文献

1
PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy.聚腺苷二磷酸核糖聚合酶 1(PARP1)在病理性心肌肥厚过程中与信号转导与转录激活因子 3(STAT3)相互作用,并将其保留在细胞核内的活性磷酸化状态。
Mol Cell Endocrinol. 2018 Oct 15;474:137-150. doi: 10.1016/j.mce.2018.02.020. Epub 2018 Mar 1.
2
The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.由PARP1介导的FoxO3多聚(ADP-核糖)化参与异丙肾上腺素诱导的心肌肥大。
Biochim Biophys Acta. 2016 Dec;1863(12):3027-3039. doi: 10.1016/j.bbamcr.2016.09.019.
3
PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.PARP1 与 HMGB1 相互作用,并促进其在病理性心肌肥厚中的核输出。
Acta Pharmacol Sin. 2019 May;40(5):589-598. doi: 10.1038/s41401-018-0044-4. Epub 2018 Jul 20.
4
PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy.蛋白激酶Cζ(PKCζ)与信号转导和转录激活因子3(STAT3)相互作用,并在心肌细胞肥大过程中促进其激活。
J Pharmacol Sci. 2016 Sep;132(1):15-23. doi: 10.1016/j.jphs.2016.03.010. Epub 2016 Mar 29.
5
Transactivated EGFR mediates α₁-AR-induced STAT3 activation and cardiac hypertrophy.α₁-AR 诱导的 STAT3 激活和心脏肥大由 EGFR 转导介导。
Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H1941-51. doi: 10.1152/ajpheart.00338.2011. Epub 2011 Aug 19.
6
STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy.信号转导和转录激活因子3(STAT3)的抑制参与了沉默调节蛋白6(SIRT6)对心肌细胞肥大的保护作用。
J Cardiovasc Pharmacol. 2016 Sep;68(3):204-14. doi: 10.1097/FJC.0000000000000404.
7
The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy.ALKBH5 在心肌细胞肥大中的功能作用。
Cell Death Dis. 2024 Sep 18;15(9):683. doi: 10.1038/s41419-024-07053-2.
8
Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway.热休克转录因子 1 通过 JAK2/STAT3 通路在缺血诱导的心肌肥厚中起关键作用。
J Cell Mol Med. 2018 Sep;22(9):4292-4303. doi: 10.1111/jcmm.13713. Epub 2018 Jul 11.
9
Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.原儿茶醛通过抑制 JAK2/STAT3 信号通路保护异丙肾上腺素诱导的心肌肥厚。
Naunyn Schmiedebergs Arch Pharmacol. 2018 Dec;391(12):1373-1385. doi: 10.1007/s00210-018-1556-7. Epub 2018 Aug 21.
10
Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.聚(ADP-核糖)聚合酶(PARP)和 PARP 抑制剂:作用机制及在心血管疾病中的作用。
Cardiovasc Toxicol. 2018 Dec;18(6):493-506. doi: 10.1007/s12012-018-9462-2.

引用本文的文献

1
Respiratory Virus-Induced PARP1 Alters DC Metabolism and Antiviral Immunity Inducing Pulmonary Immunopathology.呼吸道病毒诱导 PARP1 改变 DC 代谢和抗病毒免疫,从而诱导肺部免疫病理。
Viruses. 2024 Jun 4;16(6):910. doi: 10.3390/v16060910.
2
Identification of a Hydrogen-Sulfide-Releasing Isochroman-4-One Hybrid as a Cardioprotective Candidate for the Treatment of Cardiac Hypertrophy.鉴定一种释放硫化氢的异喹啉酮-4-酮类混合物作为治疗心肌肥厚的心脏保护候选药物。
Molecules. 2022 Jun 27;27(13):4114. doi: 10.3390/molecules27134114.
3
The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy.
C/EBPβ 在 K134 位点的 PAR 化与 SUMO 化之间的串扰参与病理性心肌肥厚。
Int J Biol Sci. 2022 Jan 1;18(2):783-799. doi: 10.7150/ijbs.65211. eCollection 2022.
4
Interplay between ADP-ribosyltransferases and essential cell signaling pathways controls cellular responses.ADP核糖基转移酶与基本细胞信号通路之间的相互作用控制着细胞反应。
Cell Discov. 2021 Nov 2;7(1):104. doi: 10.1038/s41421-021-00323-9.
5
Schisandrin Protects against Norepinephrine-Induced Myocardial Hypertrophic Injury by Inhibiting the JAK2/STAT3 Signaling Pathway.五味子醇甲通过抑制JAK2/STAT3信号通路预防去甲肾上腺素诱导的心肌肥厚损伤。
Evid Based Complement Alternat Med. 2021 Jun 16;2021:8129512. doi: 10.1155/2021/8129512. eCollection 2021.
6
Induced Mitochondrial Alteration and DNA Damage via IFNGR-JAK2-STAT1-PARP1 Pathway Facilitates Viral Hepatitis Associated Hepatocellular Carcinoma Aggressiveness and Stemness.通过IFNGR-JAK2-STAT1-PARP1途径诱导的线粒体改变和DNA损伤促进病毒性肝炎相关肝细胞癌的侵袭性和干性。
Cancers (Basel). 2021 Jun 2;13(11):2755. doi: 10.3390/cancers13112755.
7
The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy.由PARP1介导的BRD4的多聚(ADP - 核糖基)化促进了病理性心脏肥大。
Acta Pharm Sin B. 2021 May;11(5):1286-1299. doi: 10.1016/j.apsb.2020.12.012. Epub 2020 Dec 14.
8
Sorting nexin 3 induces heart failure via promoting retromer-dependent nuclear trafficking of STAT3.分选连接蛋白 3 通过促进 STAT3 依赖于逆行体的核转位诱导心力衰竭。
Cell Death Differ. 2021 Oct;28(10):2871-2887. doi: 10.1038/s41418-021-00789-w. Epub 2021 May 4.
9
Temporomandibular Disorders Slow Down the Regeneration Process of Masticatory Muscles: Transcriptomic Analysis.颞下颌关节紊乱症减缓咀嚼肌的再生过程:转录组分析
Medicina (Kaunas). 2021 Apr 7;57(4):354. doi: 10.3390/medicina57040354.
10
STAT3 Suppresses Cardiomyocytes Apoptosis in CVB3-Induced Myocarditis Via Survivin.信号转导和转录激活因子3通过生存素抑制柯萨奇病毒B3诱导的心肌炎中的心肌细胞凋亡。
Front Pharmacol. 2021 Jan 25;11:613883. doi: 10.3389/fphar.2020.613883. eCollection 2020.